Segment Information (Tables)

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

Information for the Company's reportable segments for the years ended December 31, 2016 and December 31, 2015, and for the period from February 26, 2014 (inception) to December 31, 2014 are as follows:

Year Ended December 31, 2016	Consumer Operations		Drug Development	Corporate	Consolidated
Total revenue	$	1,010,663	—	—	$	1,010,663
Loss from operations	$	10,023,137	19,620,338	10,242,757	$	39,886,232
Interest income, net	$	—	—	393,109	$	393,109

Year Ended December 31, 2015	Consumer Operations		Drug Development	Corporate	Consolidated
Total revenue	$	—	—	—	$	—
Loss from operations	$	7,892,584	12,224,692	9,096,382	$	29,213,658
Interest income, net	$	—	—	72,028	$	72,028

Period from February 26, 2014 (Inception) to December 31, 2014	Consumer Operations		Drug Development	Corporate	Consolidated
Total revenue	$	—	—	—	$	—
Loss from operations	$	898,504	4,003,911	3,127,391	$	8,029,806
Interest income, net	$	—	—	18,946	$	18,946